56 results
DEFA14A
ALGS
Aligos Therapeutics Inc
29 Apr 24
Additional proxy soliciting materials
4:04pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
P.O. BOX 8016, CARY, NC 27512
PRE 14A
ALGS
Aligos Therapeutics Inc
16 Apr 24
Preliminary proxy
5:27pm
Materials
Soliciting Material under §240.14a-12
ALIGOS THERAPEUTICS, INC.
(Name of Registrant as Specified in its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
ALIGOS THERAPEUTICS, INC
SC TO-I
EX-99
rxjvx44araa3
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
j0i2q80rca7zmd5b0
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
j280a5ke tjuc
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
pbpcsik
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
y6mnnf6d
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
s9xw6626xpnk 034z8v
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
fxmxb0pru 37d
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-I
EX-99
jdqftyhp0f4p b0
30 Jan 24
Issuer tender offer statement
7:04am
SC TO-C
rsmayws5n5k
25 Jan 24
Information about tender offer
6:12am
8-K
0m0pzfjpie8bc q0tkeq
25 Jan 24
Other Events
6:06am
8-K
EX-99.1
n4li milkr
25 Jan 24
Other Events
6:06am
D
xg9jz01x7odhmzf7w0a
7 Nov 23
$92.15 mm in equity / options / securities to be acquired, sold $92.15 mm, 11 investors
12:03pm
8-K
EX-10.1
r8vde2zgcc2i v8
25 Oct 23
Entry into a Material Definitive Agreement
5:05pm